Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 13
Blood and Lymphatic Cancer: Targets and Therapy
ISSN: 1179-9889
- View all (103)
- Volume 14, 2024 (2)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Archive: Volume 13, 2023
Polycythemia Vera: Barriers to and Strategies for Optimal Management
Duminuco A, Harrington P, Harrison C, Curto-Garcia N
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:77-90
Published Date: 21 December 2023
Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review
Alsuhebany N, Pan C, Holovac E, Do B, McBride A
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:67-76
Published Date: 24 November 2023
90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases
Wang J, Baidoun F, Tun HW, Alhaj Moustafa M
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:59-65
Published Date: 3 October 2023
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article
Hussain M, Yellapragada S, Al Hadidi S
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:33-57
Published Date: 15 September 2023
Successful Anatomy Adapted Therapeutic Management and Genetic Profiling of Primary Pituitary Diffuse Large B-Cell Lymphoma
Kimbrough EO, Gupta V, Jiang L, Tun HW
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:25-32
Published Date: 28 July 2023
Human Immunodeficiency Virus Related Non-Hodgkin’s Lymphoma
Gessese T, Asrie F, Mulatie Z
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:13-24
Published Date: 29 May 2023
PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise
Bou Zeid N, Yazbeck V
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:1-12
Published Date: 8 March 2023